Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris

Galderma

Status and phase

Completed

Phase 4

Conditions

Acne Vulgaris

Treatments

Other: Cetaphil® Dermacontrol Moisturizer SPF30

Other: Dermotivin® Soft Liquid cleanser

Drug: Benzoyl Peroxide

Study type

Interventional

Funder types

Industry

Identifiers

NCT02589405

RD.03.SPR.105041

Details and patient eligibility

About

The aim of this study is to evaluate a complete acne regimen consisting of a medication (Benzaknen® 5% Gel), and 2 cosmetic products Dermotivin® Soft Liquid soap and Cetaphil® Dermacontrol Moisturizer SPF30 in patients with acne.

Full description

The main objective of this study is to evaluate subject satisfaction with the treatment regimen comprising Benzaknen® 5% Gel in association with 2 cosmetic products including a foam soap, Dermotivin® Soft Liquid soap, and a non comedogenic moisturizer, Cetaphil® Dermacontrol Moisturizer SPF30, in patients with mild to moderate acne, after 12 weeks of treatment.

Enrollment

50 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male or female subject of any ethnic background of 12 years or older.
Subject with mild or moderate facial acne vulgaris defined as an Investigator Global Assessment (IGA) score at 2 or 3 on a 0-4 scale.
Subject with any skin phototype according to T.B. Fitzpatrick skin phototype definitions.

Exclusion criteria

Subject with severe acne (IGA>3) with nodules, cysts, scars or extra-facial lesions,
Female subject who is pregnant, lactating or planning a pregnancy during the study,
Subject susceptible to take a corticosteroid treatment during the study except inhaled or topic when needed to treat a condition outside the face,